Tenet Healthcare Corporation (NYSE:THC) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Tenet Healthcare Corporation (NYSE:THC) have earned a consensus recommendation of “Moderate Buy” from the twenty-two analysts that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, eighteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $247.6667.

THC has been the subject of a number of research reports. KeyCorp lifted their price target on Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Truist Financial upped their target price on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Guggenheim raised their price target on shares of Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research report on Friday, February 13th. UBS Group increased their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Finally, Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th.

Tenet Healthcare Price Performance

Shares of THC stock opened at $238.68 on Monday. The firm has a market capitalization of $20.76 billion, a price-to-earnings ratio of 15.41, a PEG ratio of 1.18 and a beta of 1.44. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The stock’s 50-day simple moving average is $206.02 and its 200-day simple moving average is $199.74. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $240.83.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same quarter in the previous year, the firm earned $3.44 EPS. Tenet Healthcare’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts forecast that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares in the company, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.81% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in THC. Triumph Capital Management acquired a new stake in Tenet Healthcare during the third quarter valued at $25,000. Activest Wealth Management purchased a new position in shares of Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare in the 4th quarter worth about $29,000. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $32,000. Finally, Westside Investment Management Inc. increased its position in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after buying an additional 96 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.